Particularly, in pancreatic cancer cells GSK3β pathway was associated with increased NFκB activity, increased cancer cell survival [24], tumor dedifferentiation [19] and tumor resistance [25, 26]. The gene discussed is GSK3B; the disease is pancreatic neoplasm.